Molecular formula: | C39H53N5O7 |
Average mass: | 703.881 |
Monoisotopic mass: | 703.394499 |
ChemSpider ID: | 412588 |
4 of 4 defined stereocentres
191594-64-6
[RN]4ZE7DBE752
[UNII][(5S,10S,11S,14S)-11-Benzyl-8-(4-biphénylylméthyl)-10-hydroxy-15,15-diméthyl-5-(2-méthyl-2-propanyl)-3,6,13-trioxo-2-oxa-4,7,8,12-tétraazahexadécan-14-yl]carbamate de méthyle
[French]
[ACD/IUPAC Name][(5S,10S,11S,14S)-11-Benzyl-8-(4-biphénylylméthyl)-10-hydroxy-15,15-diméthyl-5-(2-méthyl-2-propanyl)-3,6,13-trioxo-2-oxa-4,7,8,12-tétraazahexadécan-14-yl]carbamate de méthyle (non-preferred name)
[French]
[ACD/IUPAC Name]Butanoic acid, 2-[(methoxycarbonyl)amino]-3,3-dimethyl-, 2-([1,1′-biphenyl]-4-ylmethyl)-2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-1-oxobutyl]amino]-4-phenylbutyl]hydrazide, (2S)-
[ACD/Index Name]butanoic acid, 2-[(methoxycarbonyl)amino]-3,3-dimethyl-, 2-([1,1′-biphenyl]-4-ylmethyl)-2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-1-oxobutyl]amino]-4-phenylbutyl]hydrazide, (2S)-
Methyl [(5S,10S,11S,14S)-11-benzyl-8-(4-biphenylylmethyl)-10-hydroxy-15,15-dimethyl-5-(2-methyl-2-propanyl)-3,6,13-trioxo-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate
[ACD/IUPAC Name]Methyl [(5S,10S,11S,14S)-11-benzyl-8-(4-biphenylylmethyl)-10-hydroxy-15,15-dimethyl-5-(2-methyl-2-propanyl)-3,6,13-trioxo-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate (non-preferred name)
[ACD/IUPAC Name]Methyl-[(5S,10S,11S,14S)-11-benzyl-8-(4-biphenylylmethyl)-10-hydroxy-15,15-dimethyl-5-(2-methyl-2-propanyl)-3,6,13-trioxo-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamat
[German]
[ACD/IUPAC Name]Methyl-[(5S,10S,11S,14S)-11-benzyl-8-(4-biphenylylmethyl)-10-hydroxy-15,15-dimethyl-5-(2-methyl-2-propanyl)-3,6,13-trioxo-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamat (non-preferred name)
[German]
[ACD/IUPAC Name]N-{(2S,3S)-4-[1-(biphenyl-4-ylmethyl)-2-{(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanoyl}hydrazinyl]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(methoxycarbonyl)-3-methyl-L-valinamide
((S)-1-{N′-Biphenyl-4-ylmethyl-N′-[(2S,3S)-2-hydroxy-3-((S)-2-methoxycarbonylamino-3,3-dimethyl-butyrylamino)-4-phenyl-butyl]-hydrazinocarbonyl}-2,2-dimethyl-propyl)-carbamic acid methyl ester
1-(4-Biphenylyl)-4(S)-hydroxy-5(S)-2,5-bis((N-(methoxycarbonyl-)-L-tert-leucinyl)amino)-6-phenyl-2-azahexane
1-(4-Biphenylyl)-4(S)-hydroxy-5(S)-2,5-bis{[N-(methoxycarbonyl-)-L-tert-leucinyl]amino}-6-phenyl-2-azahexane
Aza-Dipeptide analogue
METHYL N-[(1S)-1-(N′-{[1,1′-BIPHENYL]-4-YLMETHYL}-N′-[(2S,3S)-2-HYDROXY-3-[(2S)-2-[(METHOXYCARBONYL)AMINO]-3,3-DIMETHYLBUTANAMIDO]-4-PHENYLBUTYL]HYDRAZINECARBONYL)-2,2-DIMETHYLPROPYL]CARBAMATE
methyl N-[(1S)-1-[[(1S,2S)-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[(4-phenylphenyl)methyl]amino]-1-(phenylmethyl)propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate
methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-phenylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate
methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[(4-phenylphenyl)methyl]amino]-1-phenyl-butan-2-yl]amino]-3,3-dimethyl-1-oxo-butan-2-yl]carbamate
methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-phenylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate
N-[(1S)-1-[[[(1S,2S)-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-1-oxobutyl]amino]-[(4-phenylphenyl)methyl]amino]-1-(phenylmethyl)propyl]amino]-oxomethyl]-2,2-dimethylpropyl]carbamic acid methyl esterN-[(1S)-1-[[(1S,2S)-1-(benzyl)-3-[[[(2S)-2-(carbomethoxyamino)-3,3-dimethyl-butanoyl]amino]-(4-phenylbenzyl)amino]-2-hydroxy-propyl]carbamoyl]-2,2-dimethyl-propyl]carbamic acid methyl ester
n-{(2s,3s)-4-[1-(biphenyl-4-ylmethyl)-2-{(2s)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanoyl}hydrazinyl]-3-hydroxy-1-phenylbutan-2-yl}-n2-(methoxycarbonyl)-3-methyl-l-valinamide